Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

165
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
165
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
Nephrons01:10

Nephrons

3.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Guava Leaf Extract Exhibits Antimicrobial Activity in Extensively Drug-Resistant (XDR) <i>Acinetobacter baumannii</i>.

Molecules (Basel, Switzerland)·2025
Same author

Occurrence of Plasmid-Mediated Quinolone Resistance and Carbapenemase-Encoding Genes in <i>Pseudomonas aeruginosa</i> Isolates from Nosocomial Patients in Aguascalientes, Mexico.

Pathogens (Basel, Switzerland)·2024
Same author

Association of perinatal exposition to xenobiotics with kidney volume at birth.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2024
Same author

Biofilm Formation by <i>Escherichia coli</i> Isolated from Urinary Tract Infections from Aguascalientes, Mexico.

Microorganisms·2023
Same author

Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial.

Transplant infectious disease : an official journal of the Transplantation Society·2022
Same author

Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin.

Clinical kidney journal·2022

相关实验视频

Updated: Sep 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

862

多因子慢性病多因子慢性病

Jose Manuel Arreola Guerra1, Jesus-Israel Martinez-Martinez2

  • 1Centenario Hospital Miguel Hidalgo - Nephrology, Aguascalientes, Mexico, Instituto para la atención integral de enfermedades renales del estado de Aguascalientes, Aguascalientes, Mexico.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|July 4, 2025
PubMed
概括
此摘要是机器生成的。

慢性病 (CKD) 是一个日益严重的全球健康问题,具有不同的区域影响. 了解它的多因素原因和损伤途径是制定有效的全球预防和治疗策略的关键.

关键词:
血压 血压 血压 血压慢性功能衰竭 慢性功能衰竭糖尿病病 糖尿病病葡萄糖样硬化症 葡萄糖样硬化症间歇性纤维化 间歇性纤维化

更多相关视频

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.6K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

285

相关实验视频

Last Updated: Sep 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

862
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.6K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

285

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 流行病学 流行病学
  • 心血管医学 心血管医学

背景情况:

  • 慢性病 (CKD) 的负担在全球范围内显著增加,在各地区存在差异.
  • 最近的临床试验强调了-葡萄糖-同载体-2 (SGLT2) 抑制剂对心血管和脏健康的保护作用.
  • 人们越来越了解病损伤途径,包括免疫学,毒性和遗传因素,强调CKD的多因素性质.

研究的目的:

  • 强调慢性病 (CKD) 的多因素性质.
  • 强调了解终身初级伤害途径的重要性.
  • 强调需要进行特定区域的流行病学研究,以解决全球CKD负担的异质性.

主要方法:

  • 审查最近的临床试验数据,特别关注SGLT2抑制剂.
  • 对损伤途径 (免疫学,毒性,遗传学) 的已知知识的分析.
  • 考虑影响子数和终身暴露的发育因素.

主要成果:

  • 通过共同的保护途径,SGLT2抑制剂在减少心血管死亡率和CKD进展方面表现出有效性.
  • 慢性瘤的发病包括从产前发育到终身暴露和病理的多个因素.
  • 在CKD负担中存在显著的区域异质性,需要进行本地化研究.

结论:

  • 慢性瘤是一种复杂的多因素疾病,受遗传学,环境和终身暴露的影响.
  • 对各种伤害机制的全面了解对于缓解CKD至关重要.
  • 定制的,特定区域的流行病学研究对于有效的全球性CKD管理和预防至关重要.